Otonomy Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Otonomy Inc.

Otonomy Inc. | Ownership

Companies that own Otonomy Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Wellington Management Co. LLP

3,606,961

11.8%

-73,810

06/30/2018

First Manhattan Co.

1,902,000

6.22%

0.03%

06/30/2018

Dimensional Fund Advisors LP

1,406,221

4.59%

282,202

06/30/2018

Renaissance Technologies LLC

1,354,800

4.43%

338,100

06/30/2018

The Vanguard Group, Inc.

1,007,825

3.3%

-96,317

06/30/2018

D. E. Shaw & Co. LP

884,026

2.89%

66,818

06/30/2018

683 Capital Management LLC

800,000

2.62%

150,000

0.27%

06/30/2018

BlackRock Fund Advisors

791,667

2.59%

-1,140,881

06/30/2018

Millennium Management LLC

596,329

1.95%

479,271

06/30/2018

Numeric Investors LLC

421,482

1.38%

38,882

0.01%

06/30/2018

About Otonomy

View Profile

Address	4796 Executive Drive San Diego California 92121 United States
Employees	-
Website	http://www.otonomy.com
Updated	07/08/2019
Otonomy, Inc. is a biopharmaceutical company, which engages in the research, development, and manufacture of therapeutics for otology. The firm's portfolio includes therapeutics for diseases and disorders of the ear such as Ménière's disease, tinnitus, synaptopathy hearing loss, cisplatin-induced loss, severe hearing loss, TTP surgery, and acute otitis externa. It operates under the Otiprio brand.